HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)

PHASE3CompletedINTERVENTIONAL
Enrollment

405

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

January 31, 2016

Conditions
Paroxysmal Atrial Fibrillation
Interventions
DEVICE

EAS-AC (HeartLight)

Pulmonary vien isolation

PROCEDURE

Control Arm Ablation

Treatment with standard ablation.

Trial Locations (21)

10029

Mt. Sinai Hospital, New York

19104

Hospital of the University of Pennsylvania, Philadelphia

21287

Johns Hopkins, Baltimore

22908

University of Virginia Health System, Charlottesville

23507

Sentara Cardiovascular Research Institute, Norfolk

27710

Duke University, Durham

29425

Medical University South Carolina, Charleston

48072

Beaumont Hospital, Royal Oak

55902

Mayo Clinic Rochester/St. Mary's Hospital, Rochester

62701

Prairie Heart Institute, Springfield

77030

Methodist Hospital, Houston

78705

Texas Cardiac Arrhythmia Research Foundation, Austin

90404

Pacific Heart Institute, Santa Monica

94143

UCSF, San Francisco

94305

Stanford Hospital, Palo Alto

95819

Regional Cardiology Associates, Mercy General Hospital, Sacramento

Unknown

University of Alabama, Birmingham, Birminham

The University of Kansas Medical Center, Kansas City

Intermountain Medical Center, Murray

32224-1865

Mayo Clinic Jacksonville, Jacksonville

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CardioFocus

INDUSTRY